Medical News

RSS
UCI researchers receive $3.4 million grant to study new class of cancer killing immunotherapeutics

UCI researchers receive $3.4 million grant to study new class of cancer killing immunotherapeutics

Cidara initiates Phase 3 clinical trial to evaluate efficacy, safety of rezafungin to treat invasive candidiasis

Cidara initiates Phase 3 clinical trial to evaluate efficacy, safety of rezafungin to treat invasive candidiasis

FLX Bio treats first patient in its Phase 1/2 clinical trial of FLX475 for treating various advanced cancers

FLX Bio treats first patient in its Phase 1/2 clinical trial of FLX475 for treating various advanced cancers

CytoSen receives favorable response from FDA to its pre-IND meeting package for CSTD002-NK

CytoSen receives favorable response from FDA to its pre-IND meeting package for CSTD002-NK

Fina Biosolutions receives patent for expression and purification of the conjugate vaccine protein

Fina Biosolutions receives patent for expression and purification of the conjugate vaccine protein

Alnylam announces positive results from Phase 3 Study of givosiran for treating acute hepatic porphyria

Alnylam announces positive results from Phase 3 Study of givosiran for treating acute hepatic porphyria

Researchers define specific neuropsychological profile of alcoholic abusers

Researchers define specific neuropsychological profile of alcoholic abusers

Decibel obtains exclusive license to commercialize ORC-13661 for preventing hearing, balance disorders

Decibel obtains exclusive license to commercialize ORC-13661 for preventing hearing, balance disorders

Natural wood-based bioactive substances combat antimicrobial resistance in hospitals

Natural wood-based bioactive substances combat antimicrobial resistance in hospitals

Study: PVC-floored homes are source of phthalate uptake in pregnant women

Study: PVC-floored homes are source of phthalate uptake in pregnant women

Medtronic announces U.S. launch of Infinity OCT System

Medtronic announces U.S. launch of Infinity OCT System

Updated model of PAXMAN Scalp Cooling System launched

Updated model of PAXMAN Scalp Cooling System launched

Cornwall and Chongqing Haifu partners to introduce HIFU tumor therapy system

Cornwall and Chongqing Haifu partners to introduce HIFU tumor therapy system

OrthoSera presents first-in-man study results of hyperacute serum in knee osteoarthritis

OrthoSera presents first-in-man study results of hyperacute serum in knee osteoarthritis

Limiting your child's screen time could improve cognition

Limiting your child's screen time could improve cognition

Emphasizing the need to educate future medical professionals on concept of machine learning

Emphasizing the need to educate future medical professionals on concept of machine learning

Novel therapy technique double rate of upper limb recovery in stroke patients

Novel therapy technique double rate of upper limb recovery in stroke patients

EU conducts research into mechanisms and effects of atrial fibrillation

EU conducts research into mechanisms and effects of atrial fibrillation

GARDP partners with Novartis to accelerate development of generic antibiotic treatments for children

GARDP partners with Novartis to accelerate development of generic antibiotic treatments for children

AVITA Medical announces results revealing safety, effectiveness of RECELL System for burn care

AVITA Medical announces results revealing safety, effectiveness of RECELL System for burn care

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.